| 0 (0%) | 09-27 09:34 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 15.69 | 1-year : | 18.33 |
| Resists | First : | 13.43 | Second : | 15.69 |
| Pivot price | 12.72 |
|||
| Supports | First : | 12.28 | Second : | 11.56 |
| MAs | MA(5) : | 12.98 |
MA(20) : | 12.57 |
| MA(100) : | 9.84 |
MA(250) : | 8.79 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.4  |
| %K %D | K(14,3) : | 65.6 |
D(3) : | 67.7 |
| RSI | RSI(14): 65.7 |
|||
| 52-week | High : | 13.43 | Low : | 6.55 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ AUPH ] has closed below upper band by 14.9%. Bollinger Bands are 20.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 13.16 - 13.24 | 13.24 - 13.31 |
| Low: | 12.61 - 12.71 | 12.71 - 12.8 |
| Close: | 13 - 13.13 | 13.13 - 13.27 |
Wed, 24 Sep 2025
Strs Ohio Buys New Shares in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Tue, 23 Sep 2025
Acropolis Investment Management LLC Invests $242,000 in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Mon, 22 Sep 2025
Aurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 1-Year High - Here's What Happened - MarketBeat
Sun, 07 Sep 2025
Are Strong Financial Prospects The Force That Is Driving The Momentum In Aurinia Pharmaceuticals Inc.'s NASDAQ:AUPH) Stock? - simplywall.st
Tue, 12 Aug 2025
How Aurinia Pharmaceuticals' Strong Q2 Results and Buyback Expansion Will Impact AUPH Investors - simplywall.st
Wed, 06 Aug 2025
Aurinia Pharma: The Easiest Money May Have Been Made (Rating Downgrade) (NASDAQ:AUPH) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 132 (M) |
| Held by Insiders | 1.2806e+008 (%) |
| Held by Institutions | 7.1 (%) |
| Shares Short | 9,160 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 66.69 |
| Profit Margin | 23.3 % |
| Operating Margin | 28.8 % |
| Return on Assets (ttm) | 7.6 % |
| Return on Equity (ttm) | 17.3 % |
| Qtrly Rev. Growth | 22.3 % |
| Gross Profit (p.s.) | 1.64181e+008 |
| Sales Per Share | 2.04811e+008 |
| EBITDA (p.s.) | 6.50236e+007 |
| Qtrly Earnings Growth | 3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 93 (M) |
| PE Ratio | 30.55 |
| PEG Ratio | 0 |
| Price to Book value | 0.19 |
| Price to Sales | 0 |
| Price to Cash Flow | 6.59 |
| Dividend | 0 |
| Forward Dividend | 8.93e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|